Case Study: Pfizer Transforms Operations with AI

Pfizer, a global leader in the biopharmaceutical industry with a revenue of $59 billion, has embarked on a comprehensive integration of artificial intelligence (AI) across its operations. This initiative spans multiple functions, including People Experience (HR), Talent Acquisition (Candidate Experience), marketing, and clinical trial data management. By leveraging AI, Pfizer aims to enhance recruitment processes, internal mobility, marketing efficiency, and data quality in clinical trials.

Key Takeaways

• AI has significantly streamlined HR processes at Pfizer, improving job descriptions, candidate matching, and internal mobility.
• The “Charlie” platform has enhanced marketing efficiency, aiding in content creation, legal reviews, and customer insights.
• Generative AI and centralized statistical monitoring have improved data quality and oversight in clinical trials.
• The implementation of Visier has democratized data access, fostering data-driven decision-making across the organization.

Approach

Pfizer’s AI strategy began with a directive from the CEO, urging each function to identify AI use cases that provide tangible value. The People Experience team focused on improving hiring efficiency and candidate experience, while the marketing and clinical trial management teams developed AI-driven solutions to enhance their respective operations. This comprehensive approach ensured that AI was leveraged effectively across multiple facets of the organization.

Implementation

In HR, Pfizer utilized generative AI to develop precise and consistent job descriptions, ensuring they were accurate and aligned with job levels. AI tools like HiredScore assessed candidates’ fit for job descriptions and suggested suitable internal candidates for open roles. During the interview process, AI generated relevant questions and summarized interview content, providing recruiters and hiring managers with clear candidate insights. AI also facilitated internal mobility by matching internal candidates to roles based on their skills, experiences, and growth aspirations. Additionally, Microsoft Copilot assisted in drafting organization-wide announcements for new hires, saving time and ensuring consistent communication.

Pfizer partnered with vendors like HiredScore and Willis Towers Watson to ensure ethical AI practices and unbiased job grading. The implementation of Visier provided real-time data access and updates, enhancing workforce planning and internal mobility.

In marketing, Pfizer developed the “Charlie” platform, a generative AI tool that aids in content creation, editing, fact-checking, and legal reviews. It integrates with Adobe platforms and Slack to enhance communication and collaboration across marketing teams. This platform optimizes content creation processes, triples content production, and ensures accurate, regulatory-compliant messaging. AI also gathers insights across therapeutic areas to better understand customer needs and tailor marketing strategies accordingly.

In clinical trials, generative AI improved data review processes, ensuring data quality and integrity. Centralized statistical monitoring identified anomalies in electronic diary entries, ensuring accurate and reliable data. AI also utilized audit trails to verify each step in the data handling process, ensuring transparency and accountability.

Results

The integration of AI tools has significantly reduced the time spent on drafting job descriptions, matching resumes, and preparing interview questions. AI has facilitated proactive internal recruitment, ensuring that employees are aware of and can apply for suitable internal opportunities. Microsoft Copilot has streamlined the process of announcing new hires and job changes across the organization. The “Charlie” platform has increased content production efficiency and accuracy in marketing, ensuring regulatory compliance. Generative AI and centralized statistical monitoring have improved data quality and oversight in clinical trials.

Challenges and Barriers

Ensuring AI systems have access to high-quality, consistent data has been a critical challenge, addressed through rigorous validation and monitoring processes. Maintaining ethical standards in AI implementation necessitates careful vendor selection and ongoing audits. Promoting AI fluency across the organization is essential to ensure employees understand and effectively use AI tools in their daily work.

Future Outlook

Pfizer aims to expand AI fluency across its nearly 80,000 employees, integrating AI into daily tasks to enhance productivity and uncover new opportunities. The company plans to continue exploring AI applications in other areas, such as marketing and clinical trial data management, to drive further innovation and efficiency.

To get the latest AI transformation case studies straight to your inbox, subscribe to AI in Action by AIX — your weekly newsletter dedicated to the exploration of AI adoption in business.

Elevate your understanding of AI transformation. Browse AI adoption case studies searchable by company, industry, use case, and technology.

Sources:
Pfizer: HR, don’t just focus on AI use cases, you also need organization-wide AI fluency
Pfizer marks a new chapter in AI and gene therapy
How Pfizer Uses AI to Transform Clinical Trial Data Oversight
With ‘Charlie,’ Pfizer is building a new generative AI platform for pharma marketing
Pfizer collab with Austrian research institute leads to new AI models for drug discovery

Let’s talk

Whether you’re looking for expert guidance on AI transformation or want to share your AI knowledge with others, our network is the place for you. Let’s work together to build a brighter future powered by AI.